^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HS-10375

    i
    Other names: HS-10375
    Associations

    News

    Trials
    Company:
    Jiangsu Hansoh Pharma
    Drug class:
    EGFR inhibitor, EGFR C797S inhibitor
    Related drugs:
    Associations

    News

    Trials
    almost2years
    Hase 1/2 Study of HS-10375 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC) (clinicaltrials.gov)
    P1/2, N=354, Recruiting, Jiangsu Hansoh Pharmaceutical Co., Ltd.
    New P1/2 trial
    |
    EGFR (Epidermal growth factor receptor)
    |
    EGFR mutation • EGFR C797S
    |
    HS-10375